ABSTRACT BACKGROUND: Chest injuries, accounting for 25% of all trauma-related deaths, are one of the main causes of death in young adults. Our priority is the early identification of life-threatening injuries both immediate and delayed. The role of various biomarkers, such as Clara cell protein 16, von Willebrand factor, interleukin-6, tumor necrosis factor, and angiopoietin, has been studied in trauma-related acute respiratory distress syndrome (ARDS). Serum angiotensin-converting enzyme (ACE) levels have been studied in non-trauma-related ARDS. The aim of this prospective observational study was to evaluate the role of ACE levels as a prognostic marker in thoracic trauma.
which plays a central role in generating angiotensin II from angiotensin I in the renin-angiotensin system (RAS), assumes importance because the capillary blood vessels in the lung are one of the major sites of ACE expression and angiotensin II production in the human body. [8] Though the role of RAS has been implicated in the pathogenesis of pulmonary hypertension and pulmonary fibrosis in chronic lung diseases, [9] recent studies indicate that the RAS also plays a critical role in acute lung injury and ARDS. [9] Thoracic trauma also increases the chances of acute lung injury and ARDS with or without fatality. Thus, the RAS appears to play a critical role in the pathogenesis of trauma-related acute lung injury. Therein lie the possibility of therapeutic altering of ACE activity to affect the prognostic outcome in severe thoracic trauma. Therefore, we planned a prospective observational study to
INTRODUCTION
Chest injuries, accounting for 25% of all trauma-related deaths, are one of the main causes of death in young adults. [1] These injuries can be managed by pain management, oxygenation, tube thoracostomy, or surgery. Mortality can occur immediately after thoracic injury or in the delayed phase due to respiratory failure. [1] The early identification of patients with trauma-related acute respiratory distress syndrome (ARDS) with grave prognosis is of utmost importance, and various biomarkers in blood and bronchoalveolar lavage fluid have been studied till date in this regard, e.g., Clara cell protein 16, von Willebrand factor, interleukin-6, tumor necrosis factor, angiopoietin-2, histones, selectins, and mitochondrial DNA. [2] [3] [4] [5] [6] [7] In this respect, angiotensin-converting enzyme (ACE), evaluate the levels of ACE in traumatic lung injury patients and to compare its level with Thoracic Trauma Severity Score (TTSS). We correlate the level of ACE with the outcome (discharge, ARDS, and mortality) of patients, so that its role can be established as a predictive marker for the severity and prognosis of traumatic parenchyma lung injury.
MATERIALS AND METHODS
After obtaining approval from the institutional ethical committee, this prospective observational study was conducted in the Department of Surgery, in collaboration with the Department of Biochemistry. All consecutive adult (aged >18 years) patients of isolated lung injury (blunt or penetrating) coming to the trauma center and surgery emergency of King George Medical University Lucknow, UP, India from July 2015 to August 2016 were included in the study. Informed consent was obtained from the patients. Patients with polytrauma, pre-existing pulmonary or renal disease, and any other significant co-morbid medical or surgical illness were excluded from the study. The demographic data of all patients, mode of injury, any intervention, serum ACE levels at the time admission, and outcomes (discharge, ARDS, and mortality) were evaluated.
Data Collection
After performing a thorough clinical examination, noting down associated injuries along with exclusion of patients with obvious polytrauma, chest radiograph examination and ultrasonography (focused assessment with sonography in trauma) abdomen with exclusion of patients with abdominal trauma were performed. Patient's clinical condition guided by laboratory parameters and radiological investigations was the main determinant of further management as per standard practice guidelines for thoracic trauma followed upon in the institution, and it was not affected by the observational nature of the study.
Procedure
Venous blood sample (5 mL) was withdrawn from patients with traumatic lung injury on the day of admission and stored in a deep freezer at −80 °C. It was transported in an icebox to the Department of Biochemistry for storage at −80 °C. It was centrifuged at 3000 g for 10 min for separation of serum. The estimation of serum ACE by enzyme linked immunosorbent assay (ELISA) kit was performed according to the manufacturer's protocol.
Statistical Analysis
Student's t-test was used to test the significance of the mean of two groups, and paired t-test was used to test the significance of change in variable. Chi-square test was used to test the significance of contingency tables. Values are expressed as mean and standard deviation. A p value <0.05 was accepted as significant.
RESULTS

Demographic Profile of the Patients
The duration of the study was 1 year. A total of 48 patients with isolated traumatic lung injury (by both penetrating and blunt trauma) were enrolled into the study. The mean age of the patients was 41.48±4.37 (range 13-70) years. The majority of the patients were male, with a study population of 44 (91.67%). A bimodal distribution of age was seen at maximum (n=10, %=21) between 21 and 30 years and 51 and 60 years, followed by those aged between 41 and 50 years (n=9, %=19).
Injury Pattern
Road traffic accident (n=26, %=54) followed by fall from height (n=12, %=25) were common modes of injury, whereas penetrating trauma by sharp objects (low velocity), firearm chest injury (high velocity), and bull horn injury were other modes of injury (Table 1 ). In most of the patients, lung contusion alone was the most consistent finding (50%), followed by contusion and collection of both (31%). The rest of them had collection alone (6%), subcutaneous emphysema (16%), pneumothorax (2%), and subcutaneous hematoma (2%) ( Table 1) .
Serum ACE Levels
The serum level of ACE in different patients was evaluated by using an ELISA kit, and the value varied between 30 and 90 µg/L. The mean ACE levels in our patient was 66.54±11.18. Six range groups were made viz. ≤40, 41-50, 51-60, 61-70, 71-80, and >80. Most of the patients had levels 61-70 (41%), followed by 71-80 (31%) ( Table 1) .
Thoracic Trauma Severity Score
TTSS, which consists of five grades based on PaO 2 /FiO 2 ratio, rib fracture, contusion of the lung, pleural involvement, and age of the patient, was calculated in each patient. The mean TTSS score was 8.52±4.42 (Table 1) .
Correlation of Serum ACE with the Length of Hospital Stay, Complications, and Outcome
Patients with the highest duration of hospital stay (mean 16.4±3.26 days) had higher ACE levels in the range of 71-80 µg/L, and those with the least duration of stay (2 days) had ACE levels <40 µg/L (Table 2, Fig. 1 ). Patients with ACE levels >80 µg/L had lesser hospital stay with higher incidence of expiry among them. Patients without complications had a mean level of ACE of 63.1, whereas those with complications of pneumonitis, empyema thoracis, ARDS, and sepsis had mean levels of ACE (µg/L) of 66.4, 75.3, 76.1, and 87.5, respectively (Fig. 2) .
Correlation of TTSS with the Length of Hospital Stay, Complications, and Outcome
Patients with the highest duration of hospital stay (mean 13.4 days) had higher TTSS in the range of 11-15, but TTSS was highest (16-20) in patients with a duration of stay of 9.0±1 days due to the higher incidence of expiry (Fig. 1 ). Patients without complications had a mean value of TTSS of 7.2, whereas those with complications of pneumonitis, empyema thoracis, ARDS, and sepsis had mean levels of TTSS of 9, 11.5, 13, and 17 respectively (Fig. 1) . When TTSS value was calculated for each patient, most of the patients had a range of TTSS of 6-10 (45%), followed by ranges of 11-15 (27%) and 0-5 (20%) (Fig. 2) .
Correlation of TTSS with Serum ACE Levels
On correlating TTSS and serum ACE in our patients, a strong positive correlation was found (coefficient of determination=0.86) (Fig. 3) .
DISCUSSION
Our prospective observational study on 48 patients with isolated thoracic trauma severity and ACE levels indicates that serum ACE level is increased in patients with severe thoracic trauma, complications (pneumonitis, empyema thoracis, ARDS, and sepsis), and mortality. It was also suggested that serum ACE level with a high correlation with TTSS may play a potential biomarker role for injury severity in thoracic trauma. Though there are several studies conducted on biomarkers of lung injury in ARDS, most of these were performed on nontraumatic causes of ARDS [10] [11] [12] [13] with in critical care settings and based on retrospective collection of data. Prospective studies on a novel biomarker, such as serum ACE, for prognostication of thoracic trauma patients are still lacking. Thus, the search of a biomarker for lung injury in thoracic trauma is still ongoing.
Serum ACE level may be potentially altered in thoracic trauma as pulmonary capillaries being the site of expression of ACE may be damaged in thoracic trauma. In a previous study by Orfanos et al., [14] pulmonary capillary endothelium band ACE was altered in 22 critically ill patients with a decrease in early stage acute lung injury. However, their study was conducted in an intensive care unit setting and critically ill patient only. In our prospective study, we have performed an evaluation of serum ACE levels, which were hypothesized to be increased as a result of pulmonary endothelial damage in severe thoracic trauma.
Various scoring systems, such as TTSS and Lung Organ Failure Score, have been used to predict the risk fraction of ARDS in trauma settings. In our study, we have also found an increased TTSS score in patients with complications of thoracic trauma, and a significant positive correlation was found between serum ACE levels and TTSS scores. This suggests the role of serum ACE levels as a potential prognostic marker.
The main limitation of our study is its small sample size and the non-inclusion of any radiological investigation (e.g., multiple detector computed tomography) for the evaluation of the extent of pulmonary change. One more point worth mentioning is that ACE level may be increased in inflammatory disorders, such as sarcoidosis and other medical conditions, such as diabetes, cirrhosis, hyperthyroidism, psoriasis, amyloidosis, human immunodeficiency virus, histoplasmosis, leprosy, lymphoma, and tuberculosis. Though we have excluded patients with medical disorders from our study, there is still a chance of false positive results. Future prospective studies with larger sample size with possible multi-institutional involvement and utilization of multiple regression analysis based on the prediction of risk outcome after consideration of clinical, radiological, and biochemical marker of thoracic injury along with various injury scoring systems are required for validation of our results. Nevertheless, to the best of our knowledge, this is probably the first study to evaluate the role of ACE as a prognostic marker in thoracic trauma patients.
Conclusion
Our study demonstrates that serum ACE levels are increased in thoracic trauma patients with higher levels, thereby indicat- ing the severe nature of trauma in concordance with increased TTSS scores. Thus, there exists a potential role of serum ACE levels as a prognostic marker in thoracic trauma. However, future studies are needed to support this conclusion.
